Cancer Research and Treatment

Effect of chemotherapy, immunotherapy, and targeted therapies on removal of indwelling pleural catheters in non-small cell lung cancer patients with malignant pleural effusions

Melissa Wang, Kaitlin Sparrow, Chrystal Chan, Ashley Gillson, Daniel Stollery, Pen Li

Malignant pleural effusion diagnosis and therapy

Failure pattern and radiotherapy exploration in malignant pleural effusion non-small cell lung cancer treated with targeted therapy

Qingsong Li, Cheng Hu, Shengfa Su, Zhu Ma, Yichao Geng, Yinxiang Hu, Huiqin Li, Bing Lu

Impact of thoracic tumor radiotherapy on survival in non‐small‐cell lung cancer with malignant pleural effusion treated with targeted therapy: Propensity score matching study

Qingsong Li, Cheng Hu, Shengfa Su, Zhu Ma, Yichao Geng, Yinxiang Hu, Haijie Jin, Huiqin Li, Bing Lu

EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery

Toshiya Fujiwara, Kazuhiko Shien, Motoki Matsuura, Junichi Soh, Hiromasa Yamamoto, Soshi Takao, Yuho Maki, Tsuyoshi Ueno, Ryujiro Sugimoto, Ken Suzawa, Mikio Okazaki, Hiroyuki Tao, Makio Hayama, Masafumi Kataoka, Yoshifumi Sano, Hidetoshi Inokawa, Motohir

Annals of Surgical Oncology.2023; 30(11): 6697. CrossRef

Efficacy of hyperthermic intrathoracic chemotherapy for initially diagnosed lung cancer with symptomatic malignant pleural effusion

Zihui Li, Jie Deng, Fei Yan, Li Liu, Yanling Ma, Jianhai Sun

Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs

Xinyang Du, Hua Bai, Zhijie Wang, Jianchun Daun, Zheng Liu, Jiachen Xu, Geyun Chang, Yixiang Zhu, Jie Wang

Clinical features and prognosis according to genomic mutations in primary and metastatic lesions of non‐small‐cell lung cancer

Wei Zhang, Wenjuan Han, Bo Yu, Xin Zhao, Gaojun Lu, Wendy Wu, Yi Zhang

Management of Malignant Pleural Effusion: Where Are We Now?

Seminars in Respiratory and Critical Care Medicine.2022; 43(04): 559. CrossRef

Non-Small Cell Lung Cancer with Malignant Pleural Effusion May Require Primary Tumor Radiotherapy in Addition to Drug Treatment

Qingsong Li, Cheng Hu, Shengfa Su, Zhu Ma, Yichao Geng, Yinxiang Hu, Huiqin Li, Bing Lu

Cancer Management and Research.2022; Volume 14: 3347. CrossRef

The impact of smoking status on the progression‐free survival of non‐small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta‐analysis

Xinyi Li, Cong Huang, Xiaohui Xie, Ziyang Wu, Xia Tian, Yibo Wu, Xin Du, Luwen Shi

Journal of Clinical Pharmacy and Therapeutics.2021; 46(2): 256. CrossRef

Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations

Audra J. Schwalk, David E. Ost, Sahara N. Saltijeral, Henriette De La Garza, Roberto F. Casal, Carlos A. Jimenez, Georgie A. Eapen, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Jack Lee, Yasir Elamin, Jianjun Zhang, Jack A. Roth, Stephen S

Eihab O. Bedawi, Julien Guinde, Najiib M. Rahman, Philippe Astoul

European Respiratory Review.2021; 30(159): 200002. CrossRef

Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions

Maria Alba Sorolla, Anabel Sorolla, Eva Parisi, Antonieta Salud, José M. Porcel

Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer

Tetsuo Tani, Ichiro Nakachi, Shinnosuke Ikemura, Shigenari Nukaga, Keiko Ohgino, Aoi Kuroda, Hideki Terai, Keita Masuzawa, Taro Shinozaki, Kota Ishioka, Yohei Funatsu, Hidefumi Koh, Koichi Fukunaga, Kenzo Soejima

Cancer Management and Research.2021; Volume 13: 7497. CrossRef

LENT Score: Predicting the Survival of Malignant Pleural Effusion – A Prospective Study of Three Years

Sara Raimundo, Ana Isabel Loureiro, Fortunato Vieira, Ana Fernandes

Archivos de Bronconeumología.2020; 56(7): 465. CrossRef

Current applications of molecular testing on body cavity fluids

Diagnostic Cytopathology.2020; 48(9): 840. CrossRef

Gene Alterations in Paired Supernatants and Precipitates from Malignant Pleural Effusions of Non-Squamous Non-Small Cell Lung Cancer

Jianqiang Li, Xingliang Li, Wenxian Wang, Yang Shao, Yiping Zhang, Zhengbo Song

Translational Oncology.2020; 13(8): 100784. CrossRef

Progression of malignant pleural effusion during the early stage of gefitinib treatment in advanced EGFR-mutant lung adenocarcinoma involving complex driver gene mutations

Ning Liu, Min Yu, Tao Yin, Yong Jiang, Xuelian Liao, Jie Tang, Yanying Li, Diyuan Qin, Dan Li, Yongsheng Wang

Signal Transduction and Targeted Therapy.2020;[Epub] CrossRef

LENT Score: Predicting the Survival of Malignant Pleural Effusion – A Prospective Study of Three Years

Sara Raimundo, Ana Isabel Loureiro, Fortunato Vieira, Ana Fernandes

Archivos de Bronconeumología (English Edition).2020; 56(7): 465. CrossRef

Recent Developments in the Management of Malignant Pleural Effusions: a Narrative Review

Clifford E. Coile, Jessie G. Harvey, Michal Senitko

Current Pulmonology Reports.2020; 9(4): 164. CrossRef

Detecting EGFR mutations and ALK/ROS1 rearrangements in non‐small cell lung cancer using malignant pleural effusion samples

Yi Yao, Min Peng, Qinglin Shen, Qinyong Hu, Hongyun Gong, Qingqing Li, Zhongliang Zheng, Bin Xu, Yingge Li, Yi Dong

Making cold malignant pleural effusions hot: driving novel immunotherapies

Pranav Murthy, Chigozirim N. Ekeke, Kira L. Russell, Samuel C. Butler, Yue Wang, James D. Luketich, Adam C. Soloff, Rajeev Dhupar, Michael T. Lotze

Novel insights into the systemic treatment of lung cancer malignant pleural effusion

Claire Tissot, Pierre Gay, Clément Brun, Marios E. Froudarakis

The Clinical Respiratory Journal.2019; 13(3): 131. CrossRef

Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2: effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma

Journal of the American Society of Cytopathology.2019; 8(6): 352. CrossRef